CERS2 and liver cancer: Most studies have indicated an interrelationship between low LASS2 mRNA or protein expression and the degree of poor prognosis and invasion in diseases including in liver cancer [12, 13], prostate cancer [14, 15], bladder cancer [16], breast cancer [17, 18].